The Ahmedabad-based firm had posted net profit of Rs 83.18 crore in the same period of previous fiscal.
Net sales of the company rose to Rs 768.63 crore during the third quarter, as against Rs 673.47 crore during the same period of 2011-12 fiscal.
The company's domestic formulations business grew by 13 per cent to Rs 258 crore during the third quarter, as against the same period last fiscal. The international business grew by 17 per cent to Rs 462 crore during the third quarter.
"The company declared an interim dividend of 120 per cent," Torrent said.
Torrent Pharma scrip closed at Rs 728, down 0.84 per cent on the BSE.